BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 26725424)

  • 1. Metabolism and Modification of Apolipoprotein B-Containing Lipoproteins Involved in Dyslipidemia and Atherosclerosis.
    Morita SY
    Biol Pharm Bull; 2016; 39(1):1-24. PubMed ID: 26725424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity.
    Borén J; Williams KJ
    Curr Opin Lipidol; 2016 Oct; 27(5):473-83. PubMed ID: 27472409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2.
    Dashti N; Alaupovic P; Knight-Gibson C; Koren E
    Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
    J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
    Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
    Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency.
    Ikewaki K; Cain W; Thomas F; Shamburek R; Zech LA; Usher D; Brewer HB; Rader DJ
    J Lipid Res; 2004 Jul; 45(7):1302-11. PubMed ID: 15102883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice.
    Qiu S; Bergeron N; Kotite L; Krauss RM; Bensadoun A; Havel RJ
    J Lipid Res; 1998 Aug; 39(8):1661-8. PubMed ID: 9717727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of plasma triglycerides in insulin resistance and diabetes.
    Ginsberg HN; Zhang YL; Hernandez-Ono A
    Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.
    Ebara T; Conde K; Kako Y; Liu Y; Xu Y; Ramakrishnan R; Goldberg IJ; Shachter NS
    J Clin Invest; 2000 Jun; 105(12):1807-18. PubMed ID: 10862796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
    Marathe S; Choi Y; Leventhal AR; Tabas I
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia.
    Sacks FM
    Curr Opin Lipidol; 2015 Feb; 26(1):56-63. PubMed ID: 25551803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoB-48 and apoB-100 differentially influence the expression of type-III hyperlipoproteinemia in APOE*2 mice.
    Hinsdale ME; Sullivan PM; Mezdour H; Maeda N
    J Lipid Res; 2002 Sep; 43(9):1520-8. PubMed ID: 12235184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B.
    Choi SY; Sivaram P; Walker DE; Curtiss LK; Gretch DG; Sturley SL; Attie AD; Deckelbaum RJ; Goldberg IJ
    J Biol Chem; 1995 Apr; 270(14):8081-6. PubMed ID: 7713910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.